Indrani L. Franchini left the role of Executive Vice President, Chief Legal Officer and Secretary at Alnylam Pharmaceuticals on March 1, 2024, according to an SEC filing.
| Name | Indrani L. Franchini |
|---|---|
| Role | Executive Vice President, Chief Legal Officer and Secretary |
| Company | Alnylam Pharmaceuticals |
| Industry | Biotechnology |
| Location | Cambridge, MA |
| Move | Departure |
| Date | March 1, 2024 |
| Source | an SEC filing |
Alnylam Pharmaceuticals disclosed that on January 12, 2024 it agreed with Indrani L. Franchini that she would transition from her role as executive vice president, chief legal officer and secretary, effective March 1, 2024. (Source: an SEC filing.)
Other general counsel moves in March 2024
- Daniel Goldstein Steps Down as Chief Legal Officer of Pitney Bowes (March 31, 2024)
- William L. Deckelman Jr. Steps Down as Executive Vice President and General Counsel of DXC Technology (March 31, 2024)
- Shannon Drake Steps Down as Chief Legal Officer and Secretary of Aveanna Healthcare (March 31, 2024)
- Loretta Martinez Steps Down as General Counsel of University of New Mexico (March 29, 2024)
- Shana Simmons Named Chief Legal Officer of Zendesk (March 28, 2024)
- Deborah C. Gordon Named Executive Vice President and Chief Legal Officer of Cleveland Clinic (March 27, 2024)
- Nathan O’Konek Steps Down as Executive Vice President, General Counsel and Secretary of Redwire (March 27, 2024)
- Patrick Apodaca Steps Down as Senior Vice President and General Counsel of PNM Resources (March 26, 2024)
Planning your own next move?
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.
Does this information need updating? Email us at info@inhouseblog.com.